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Abstract 
In neurons, the convergence of multiple intracellular signaling cascades leading to 
CREB activation suggests that this transcription factor plays a critical role in 
integrating different inputs and mediating appropriate neuronal responses. The nature 
of this transcriptional response depends on both the type and strength of the stimulus 
and the cellular context. CREB-dependent gene expression has been involved in many 
different aspects of nervous system function, from embryonic development to 
neuronal survival, and synaptic, structural, and intrinsic plasticity. Here, we first 
review the different methodological approaches used to genetically manipulate CREB 
activity and levels in neurons in vivo in the adult brain, including recombinant viral 
vectors, mouse transgenesis and gene targeting techniques. We then discuss the 
impact of these approaches on our understanding of CREB‟s roles in neuronal 
plasticity and memory in rodents. Studies combining these genetic approaches with 
electrophysiology and behavior provide strong evidence that CREB is critically 
involved in regulation of synaptic plasticity, intrinsic excitability and long-term 
memory formation. These findings pave the way for the development of novel 
therapeutic strategies to treat memory disorders. 
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1. Introduction 
Diverse long-lasting forms of neuronal plasticity, from changes in the number and 
strength of synaptic connections to the modulation of the intrinsic properties of 
neurons, are thought to rely on activity-driven gene expression. Although neuronal 
activity regulates the activation and/or expression of many transcription factors, the 
cAMP-responsive-element (CRE)-binding protein (CREB) is arguably the most 
studied in the context of the adult nervous system [1,2]. The activation of CREB by 
phosphorylation is triggered in neurons by a wide variety of signaling processes, from 
increases in intracellular Ca
2+
 through activation of voltage- or ligand-gated channels 
to changes in cAMP levels after activation of G-protein coupled receptors or receptor 
tyrosine kinases. Signaling upstream of CREB is very complex and overall more than 
300 different stimuli have been reported to activate CREB [2]. Downstream effects 
may be even more complex since hundreds of genes have been reported to be 
regulated by CREB in neurons. The number and identity of those CREB target genes 
will depend on both the nature of the stimulus and the cellular context [3]. A number 
of articles have reviewed different aspects of CREB‟s brain functions (e.g., 
[1,2,4,5,6,7,8,9,10,11,12]). In this review, we will describe the different methods used 
to genetically manipulate CREB activity and levels in neurons in vivo, discussing 
their individual advantages and limitations, as well as the large body of knowledge 
that has emerged from application of these complementary techniques to understand 
the role of CREB in neuronal plasticity, learning and memory.  
 
2. Genetic manipulation of CREB activity  
2.1 CREB’s structure and activation 
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CREB belongs to a family of transcription factors characterized by a highly conserved 
basic region/leucine zipper (bZIP) domain that binds to a specific DNA sequence 
called cAMP-responsive-element (CRE) found in one or several copies in the 
promoters of many genes (Mayr and Montminy, 2001). Transcriptional activation is 
mediated by two types of transactivation domains: the central kinase-inducible 
domain (KID) and the glutamine rich domains (Figure 1).  The KID contains several 
sites recognized by protein kinases and its phosphorylation state determines the 
binding of the transcriptional co-activator CREB-binding protein (CBP), which 
enables transcription initiation by bringing the RNA polymerase II complex to the 
promoter. The glutamine-rich domains contribute to basal transactivation activity by 
interacting with the transcription machinery and stabilizing the interaction with CRE 
sites. 
CREB has a complex gene structure.  Alternative splicing generates transcripts 
encoding both repressors and activators (Bartsch et al., 1998; Habener et al., 1995; 
Mayr and Montminy, 2001). The repressors are shorter variants with reduced or null 
transactivation capability that compete for CRE sites. 
Although CREB is thought to be constitutively bound to CRE sites in the 
promoters of cAMP-responsive genes, the transcription of CREB-regulated promoters 
increases several folds when CREB is phosphorylated at Serine 133 (S133) by 
activity-dependent kinases. The phosphorylated form of CREB (pCREB) can then 
recruit CBP to the promoter.  
Another important mechanism of regulation of CREB activity depends on the 
transducers of regulated CREB activity (TORC). These transcriptional co-activators, 
contrary to CBP, enhance CRE-dependent transcription through phosphorylation-
independent interaction with the bZIP domain of CREB. This interaction favors the 
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interaction of CREB with the TAF(II)130 component of the RNA polymerase II 
complex [13,14]. Although TORC proteins interact with CREB in the absence of 
phosphorylation, they are themselves substrate of kinase transduction cascades. 
The molecular knowledge described above has been used to generate CREB 
variants in which this transduction cascade is either enhanced or blocked.  
 
2.2 Gain-of-function approaches 
Four different genetic strategies have been used to increase CREB activity in neurons 
(Figure 1): 
 CREB overexpression: A number of experiments indicate that endogenous levels 
of CREB are not saturating and consequently the overexpression of wild type 
CREB can cause an enhancement of CREB-dependent signaling. 
 CREBY134F: This point mutation next to S133 increases the affinity of CREB for 
protein kinase A (PKA) (and maybe also with other activity-regulated kinases) 
and therefore leads to a reduction of the threshold for activation [15]. 
 CREBDIEDML: The mutation of 6 amino acids in the kinase-inducible domain 
(KID) of CREB allows the interaction with CBP in the absence of 
phosphorylation [16]. This mutant can therefore interact constitutively with CBP, 
although CBP activity would still be modulated by activity-dependent kinases 
[17,18].  
 VP16-CREB and CREB-VP16: The fusion between CREB or the DNA binding 
domain of CREB with the strong acidic transactivation domain of the herpes 
simplex virus (HSV) protein VP16 produces a chimeric protein that drives 
transcription from CRE-driven promoters in a constitutive manner [19]. In 
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contrast to the other approaches described above, this manipulation can effectively 
decouple CREB-dependent transcription from upstream kinase cascades. 
 
2.3 Loss-of-function approaches 
Studies investigating the consequences of reduced or absent CREB activity in 
neuronal plasticity are based in animals in which either the creb1 gene has been 
disrupted or dominant negative CREB variants are expressed (Figure 1). Three 
dominant negative mutants have been used: 
 CREBS133A (also referred as mCREB or CREB-M1): This point mutation affects 
the main residue controlling the interaction of CREB with its co-activator CBP, 
therefore rendering the protein insensitive to most activity-dependent kinase 
cascades converging on CREB. Importantly, CREB dimers, in which only one 
subunit is phosphorylated, can still activate transcription [20], which limits the 
dominant negative effect of the expression of this variant. 
 KCREB: This mutant contains a point mutation in human CREB at K304. The 
K304 residue mediates interaction with Mg
2+
 and is critical for high-affinity DNA 
binding [21]. The heterodimerization of KCREB with wild type CREB prevents 
binding to DNA. In addition, KCREB can also quench other transcription factors 
of the CREB family. 
 ACREB: This strong dominant negative variant was constructed by fusing an 
acidic amphipathic extension onto the N-terminus of the CREB leucine zipper 
region. As a result of this manipulation the protein binds with very high affinity 
and specificity to all members of the CREB family (CREB, CREM and ATF1), 
preventing dimerization and blocking their binding to CRE sites [22,23]. 
 
  7  
2.4. Methodological approaches for genetic manipulation in the brain  
The development of techniques to manipulate the genetic content of mammalian 
embryos has allowed the generation of transgenic and knockout mice and 
revolutionized biomedical research. Further progress resulting in anatomically 
restricted conditional promoters and inducible constructs have helped addressing 
challenging questions concerning the role of specific genes in complex brain 
functions, such as learning and memory. In parallel, the development and 
improvement of safe neurotropic viral vectors have provided an alternative method 
for genetic manipulation of the adult brain.  
These two general approaches for genetic manipulation in vivo are 
complementary and present distinct advantages and caveats. Mouse genetics 
approaches are time consuming in their initial steps, but once the novel mouse strain 
is generated and the pattern of expression is determined, researchers have continuous 
access to a reliable and very powerful tool to investigate gene function in vivo. By 
comparison, viral vectors can be developed more rapidly, but the experiments using 
virus are more technically demanding since it is necessary to precisely deliver the 
virus and perform post-mortem injection site analysis for each experimental animal. 
One important limitation of traditional transgenic and gene-targeting approaches is 
the limited degree of temporal and spatial control of transgene expression. Although 
this limitation can be overcome with the use of sophisticated mouse genetics 
strategies (inducible and tissue-specific mutant strains), the stereotaxic delivery of 
viral vectors can also effectively address these two issues and allows a narrow control 
of both the location and timing of the genetic manipulation.  
Genetically modified mice with altered levels of CREB function, generated by 
gene-targeting, transgenesis or viral transduction, have been investigated using a 
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combination of biochemical, anatomical, physiological and behavioral assays. Tables 
1 and 2 show, respectively, the different CREB mutant strains and recombinant 
viruses generated to investigate the function of CREB in the brain. In both cases, we 
summarize the most important results obtained concerning its role in plasticity, 
learning and memory. These experiments have enabled both the testing of pre-
existing hypothesis about the role of CREB and the discovery of novel and 
unsuspected CREB functions. 
3. Manipulating CREB function through mouse transgenesis and gene targeting  
Different strategies have been used to generate genetically modified mouse strains in 
which the expression level or the activity of CREB is directly manipulated, either to 
enhance it or to reduce it.  
 3.1. Conventional knockout mice 
First generation gene-targeting techniques were developed in the late eighties and 
allow for the selective inactivation of a specific locus in all the cells of an organism. 
The first CREB knockout mouse was produced as early as 1994 by Gunter Schütz and 
colleagues and showed some flaws associated to this incipient technology. A 
promoter-less neomycin resistance gene was inserted in frame into exon 2 [24,25], but 
this insertion did not cause the loss of CREB. Instead, it resulted in the generation of a 
hypomorphic mutant in which the creb1 locus did not produce the major isoforms of 
CREB  and  but over-expressed isoform  [26] These mice are now referred as 
CREB mice and have been investigated in dozens of publications. 
A few years later, the same group successfully generated the intended CREB 
knockout by knocking out exons 10 and 11, which encode part of the DNA binding 
domain and the leucine zipper domain. CREB null mice (CREB
-/-
) were smaller than 
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their littermates and died immediately after birth from respiratory distress [27]. 
Furthermore, CREB null mice have impaired fetal T cell development of the alpha 
beta lineage and structural brain abnormalities involving the corpus callosum and 
anterior commissures. [27].  
3.2 Conditional knockout mice 
Considering the phenotype of the full knockout, the best-suited strain to explore the 
role of CREB in the adult mouse brain would be one in which CREB is eliminated in 
adulthood. The groups of Gunter Schültz and Eric Nestler have independently 
generated two strains bearing CREB floxed alleles (creb1
f/f
 mice). The strain 
generated by Schültz‟s lab, first described in Mantamadiotis et al. 2002, bears a 
floxed allele around exon 10 in the creb1 gene and has been crossed with several Cre 
recombinase expressing lines to investigate the consequences of CREB ablation in 
different neuronal types [28,29,30,31]. Creb1
f/f
 mice have been also crossed with a 
line expressing a variant Cre recombinase regulated by tamoxifen (creERT2) under 
the control of the full CaMKIIα promoter, in which the ablation of floxed alleles is 
both spatially restricted and temporarily regulated [32]. The potential of these animals 
to dissect the requirement of CREB in different memory phases has not been 
explored. Overall, the characterization of this strain of CREB floxed mice has resulted 
in more than a dozen publications; several of them exploring the specific role of 
CREB in LTP and memory (see section 5). The second strain of creb1
f/f
 mice has 
been presented more recently and its generation was not described in detail; these 
mice have only been used to investigate the role of CREB in opiate-induced 
homeostatic adaptations of locus coeruleus neurons [33].  
3.3 Other knock-in mice  
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Gene-targeting techniques also allow for more sophisticated manipulation of CREB 
function. Thus, two point mutations have been introduced by gene-targeting 
techniques in the creb1 locus that alter the manner in which this transcription factor is 
activated by kinases. In CREB
S142A
 mice, a serine to alanine substitution at amino 
acid 142 (S142A) was introduced on exon 8 and a floxed TK-neo cassette was 
inserted into the upstream intron via homologous recombination, making this residue 
resistant to phosphorylation. Immunohistochemistry of brain sections from 
homozygous mutant animals demonstrates the absence of phosphorylation at S142, 
whereas the gene expression pattern of homozygous mutants was similar to wild-type 
CREB [34]. More recently, a knock-in CREB
S133A 
strain has been generated using a 
similar strategy [35]. Neither one of these mutants has been investigated in the 
context of plasticity and memory. The first one, however, has been used to 
demonstrate the role of phosphorylation of S142 in the regulation of circadian 
rhythms [34] and inflammatory nociception [36].  
3.4 First generation transgenics  
Classical transgenic mice express the gene-of-interest under ubiquitous or tissue-
specific promoters. The use of brain specific promoters has allowed the over-
expression of CREB or CREB mutant variants in specific neuronal populations. The 
Pcp2 promoter has been used to produce transgenic mice that over-express CREB in 
Purkinje cells and dentate gyrus granule cells [37]. The CaMKII promoter has been 
used to drive the expression of the dominant negative mutant mCREB [38] and, more 
recently, of two different dominant active variants: CREB
Y134F
 and CREB
DIEDML
 [39] 
in principal neurons of the forebrain. These three strains have been used to investigate 
the consequences of CREB inhibition or activation in neuronal plasticity and behavior 
(see section 5). 
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3.5 Second generation transgenics  
In addition to spatial specificity, temporal control is a highly desirable feature for 
transgenic mice. To address the limitations associated with constitutive transgene 
expression, great effort has been put in the development of inducible transgenic 
systems. A widely used binary system for regulated transgene expression is based on 
the bacterial tetracycline repressor developed by Gossen and Bujard [40]. There are 
two versions of this system: in the first version, the binding of the chimeric 
tetracycline-controlled transactivator tTA (resulting of the fusion of the viral trans-
activation domain VP16 and the DNA binding domain of the TetR bacterial 
repressor) is blocked by tetracycline (tet). This antibiotic is frequently replaced by 
doxycycline (dox), which also efficiently binds tTA and exhibits lower toxicity. This 
system is referred to as Tet-Off. In a second version, point mutations in tTA reversed 
the effects of tet/dox binding, this variant (rtTA) binds to DNA only when tet or dox 
are present [41]. The system is referred to as Tet-On. In both systems, the generation 
of transgenic lines in which the transgene of interest is placed downstream of the 
tTA/rtTA regulated promoter, referred to as tetO, enables its expression in a restricted 
and regulated manner. Only the tTA system has been used in the case of CREB. 
Double mutants between tetO lines and CaMKIIα-tTA mice [42] should 
express the transgene of interest in post-mitotic forebrain principal neurons. The 
expression can be temporally regulated by the addition (transgene Off) or removal 
(transgene On) of dox to the mouse diet. This approach has been used in gain-of-
function studies in which wild type CREB is over-expressed [43], or a constitutively 
active CREB variant is expressed (tetO-VP16-CREB mice, several lines first 
described in [44,45,46]), as well as loss-of-function studies based on the expression of 
dominant negative CREB variants, such as mCREB [43], KCREB (tetO-KCREB 
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mice first described in [47]) and ACREB (tetO-ACREB mice which have been 
independently generated by two research groups [48,49]). Figure 2 depicts two of 
these inducible strains. 
 A second, very useful approach to gain temporal control over transgene 
activity is the use of chimeric constructs between the protein of interest and the 
ligand-binding domain (LBD) of the estrogen receptor. The fusion protein is retained 
in the cytoplasm until the administration of tamoxifen, an estrogen receptor antagonist 
that binds to the LBD domain and causes the translocation of the protein to the 
nucleus. This approach is particularly powerful for controlling the activity of nuclear 
proteins such as the cre recombinase or transcription factors. In the case of CREB, 
Kida and colleagues generated a transgenic strain in which the dominant negative 
CREB variant mCREB was fused to the LBD domain and cloned under the control of 
the CaMKII promoter to achieve inducible repression of CREB activity in principal 
neurons of the forebrain. The rapid temporal control afforded by the tamoxifen-
regulated system, as compared to the tet system (induction in minutes as opposed to 
hours-days), allowed the investigators to use this approach to test the requirement for 
CREB in distinct phases of learning and memory [50,51]. 
 
4. Manipulating CREB function using viral-mediated in vivo protein expression  
CREB function and level have been also manipulated using viral-mediated in vivo 
expression to achieve sophisticated control of memory-encoding neuronal circuits. 
The use of viruses enables high temporal specificity and locally restricted expression 
of CREB and mutant forms of the protein. Five viral systems - the HSV, alphaviruses, 
adenovirus, adeno-associated virus and retroviruses - have been used in this context. 
Table 2 summarizes the different viruses that have been used to study the role of 
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CREB.  The currently available viral systems have been engineered for safe use, 
relying on replication-defective recombinant viruses i.e. these viruses can only infect 
cells once but cannot replicate in the infected host cell and therefore cannot propagate 
to other cells after infection. This is generally achieved by deleting essential genes 
from the viral genome necessary for replication and/or packaging. During the initial 
viral production, these genes are provided in trans (by helper DNAs or viruses). 
Below, we will briefly discuss key advantages and disadvantages of each system (see 
[52] for a recent review on this topic).  
 
4.1 Herpes simplex virus 
HSV type 1 is a 150-kb double-stranded enveloped DNA virus that carries over 75 
genes.  The recombinant viral amplicon backbone (PrpUC) contains only the minimal 
HSV-1 sequences, which allows it to be packaged into virus particles with the aid of a 
helper virus. The HSV-1 viral backbone can host large inserts of interest with good 
packaging efficiency. This virus is capable of infecting most cell lines and types of 
mammalian cells. HSV has a particular tropism for neurons. A main advantage of this 
virus is the possibility of expressing large inserts (up to 150 kb). Transgene 
expression can be detected within hours in vitro.  In vivo expression of the insert can 
be detected within days of infection, with highest transgene expression around 3 days 
after surgery. HSV is less suited for long-term expression because the viral expression 
is unstable. A limitation of this viral system, however, is that production of the viral 
particles requires a co-propagated HSV-1 helper virus, resulting in viral stocks that 
are a mixture of helper and virus of interest leading to cytotoxic effects. Efforts have 
been made to reduce this cytotoxicity, both in vitro and in vivo, with some success by 
engineering new generations of HSV vectors. To completely circumvent this problem, 
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a helper-virus free system has also been developed but yields relatively low titers of 
virus, which makes its use difficult for in vivo expression. More information on the 
HSV viral systems is provided in [53].      
 Neve and colleagues developed HSV viral vectors for use in neuroscience, and 
successfully implemented them to study the role of CREB in neuronal plasticity and 
memory formation.  Nine CREB-expressing viral vectors have been used in this 
context as detailed in Table 2.  The first generation of vectors, first reported in 
Carlezon and colleagues (Carlezon et al. 1998), contained wild-type CREB or the 
dominant negative mCREB mutant, but there was no marker of infection.  A second 
generation of vectors, that expressed either wild-type CREB, CREB
S133A
, CREB
Y134F
 
or VP16-CREB fused to GFP, allowed for live detection of the infected neurons 
[54,55].  An HSV vector with two transcriptional units driving the dominant negative 
mutant ACREB and GFP independently was also engineered by Suzuki and 
colleagues [56].  These first and second generation HSV viruses were used in vivo in 
several studies to evaluate the role of CREB in memory formation, drug addiction, 
homeostatic spine plasticity and ocular dominance plasticity (see Table 2 for details 
and references). More recently, CREB expressing HSVs has been used as a tool for 
sophisticated manipulation of neuronal circuits. The co-expression of CREB and the 
diphtheria-toxin [57] or the allatostatin receptor [58] has enabled, respectively, the 
specific erasure or reversible inactivation of recently acquired memories whose 
allocation was driven by CREB over-expression (see section 5.4 for further details). 
These two studies represent particularly good examples of how the use of viral 
vectors, with the possibility of co-expressing several proteins, provides a unique 
opportunity to modulate the function of specific neurons in vivo in a highly 
temporally and spatially restricted manner.  
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4.2 Alphaviruses: Semliki forest and sindbis viruses 
The Semliki forest and sindbis viruses are members of the alphavirus family. These 
viruses are enveloped viruses with small single-stranded RNA genomes. The first 
generation of recombinant viral backbones (pSFV, pSINRep-5), in which the insert of 
interest is cloned, also contain the non-structural genes, but lack the structural viral 
proteins normally necessary to package the RNA into viral particles.  These DNA 
constructs are used to make genome-length RNA transcripts (recombinant RNA) in 
vitro. Production of replication-deficient infectious viruses is accomplished by 
transfecting cells with the capped recombinant RNA and a helper RNA that provides 
the structural proteins in trans but does not contain a packaging sequence. Expression 
of the transgene is detected within a day both in vitro and in vivo.  More information 
on the Semliki forest and Sindbis viral systems can be found in [59]. The main 
advantages of this type of virus for use in neuroscience are that it is highly 
neurotropic (targeting preferentially glutamatergic neurons), that it allows for a strong 
and rapid expression of the transgene and that it has a good diffusion in vivo.  It 
however leads to cytotoxicity within a few days of infection and is therefore not 
suitable for long-term expression studies.  This is due to the fact that the recombinant 
RNA, once transfected into cells, promptly recruits most of the host translational 
machinery for its own use, resulting in high levels of the desired protein, but at the 
expenses of the cell‟s well-being. Also, transgene size is limited as packaging 
becomes problematic if the insert size is more than 4 kb.  In vivo investigations using 
this virus have used a time frame of expression up to 3 days with success.  A new 
generation of viral backbone vectors was designed to reduce this toxicity [60,61]. 
These low-toxicity vectors (pSFVpd and pSINRep-nsp2
S726
) contain point mutations 
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in the second non-structural protein (nsP2), which delay the inhibition of host protein 
synthesis.  For sindbis virus production using this low-toxicity vector (pSINRep-
nsP2S
726
), Kim et al. also constructed an optimized helper vector for production of 
particles with low-levels of helper RNA packaging and high neuro-specificity of 
infection [61]. 
 Zhu et al. engineered four Semliki forest viruses, using the low-toxicity 
pSFV(pd) vector, to investigate the function of CREB in ischemia-induced 
neurogenesis in the dentate gyrus (Table 2) [62]. These viruses co-expressed GFP 
with either wild-type CREB, dominant negative mutants of CREB (mCREB or 
KCREB) or the constitutively active mutant VP16-CREB. These viruses have not yet 
been used to study CREB in the context of learning and memory. 
 Investigation of the function of CREB in neuronal plasticity and memory 
using in vivo expression of sindbis viruses was reported by Marie and colleagues (see 
Table 2 and Figure 3a).  CREB
Y134F
 and CREB
S133A
, containing the FLAG tag, were 
cloned into the first generation sindbis vector which also included the coding 
sequence of GFP downstream of an internal ribosomal entry site (IRES). This 
permitted both the transgene and GFP to be translated from a single bicistronic 
mRNA in the same neurons without requiring the use of a fusion protein, which could 
disrupt normal activity of the transgene being tested. These first viruses were used in 
electrophysiological studies to identify the role of CREB in the regulation of neuronal 
physiology [63,64,65].  More recently, lower toxicity Sindbis variant viruses 
(pSINRep-nsP2S
726
), which allow for slightly longer in vivo manipulations (up to 7 
days), have been used evaluate the effects of increasing CREB activity on dentate 
gyrus synaptic plasticity and on hippocampus-dependent memory formation and 
extinction [66,67,68].  
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4.3 Adenovirus  
Adenoviruses (Ad) are medium-sized non-enveloped (without an outer lipid bilayer) 
viruses composed of a nucleocapsid and a double-stranded linear DNA genome. 
Human Ad serotype 5 is generally used for gene transfer as its biology is best 
characterized.  The first generation of adenoviral vectors was based on this serotype 
by removing the E1 early genes.  This system has however been associated with in 
vivo toxicity due to innate immune responses and inflammation. The next generation 
of Ad vectors, referred to as “gutless or “high-capacity”, have all of the viral genome 
removed providing greater transgene capacity. However, the active Ad infection still 
displays some toxicity. One of the main advantages of Ad viruses is that it can carry 
large inserts (up to 30kb for „high capacity‟ vectors). Expression of the transgene is 
slow at first requiring several days for detection in vivo, but can be used for long-term 
expression in neurons albeit the possibility of increased toxicity. Also, there is a lack 
of neurotropism as these viruses infect neurons and glia equally, which can be 
circumvented with the use of cell-specific promoters. More information on this viral 
system can be found in [69]. 
Ad viruses expressing wild type CREB and the dominant negative ACREB, 
together with IRES GFP, have been used in studies to evaluate the role of CREB in 
neuronal death [70], in perirhinal cortex plasticity and in recognition memory [71].  
Also, Gao et al. designed an Ad virus harboring both GFP and VP16-CREB, in which 
expression of the latter transgene is regulated by the Tet-Off system (see section 3.5) 
[72]. In this study, tTA was provided by another tTA-expressing adenovirus and 
VP16-CREB expression was turned on when doxycycline was removed from the diet 
of infected mice or the media of infected neuronal cultures. This virus was only used 
  18  
as yet to evaluate the role of CREB in axon regeneration in vivo [72], but this study 
proves the feasibility of combining in vivo viral expression with the inducible 
tetracycline repressor system. 
 
4.4 Adeno-associated virus 
Adeno-associated viruses (AAV) are small replication-deficient parvoviruses, which 
have traditionally required co-infection with a helper adenovirus or herpes virus for 
productive infection.  For safer use of this viral system, helper-free systems have been 
developed in which most of the adenovirus gene products required for the production 
of infective AAV particles are supplied by helper plasmids. The recombinant AAV 
(rAAV-2) serotype 2 is generally used in neuroscience because this serotype shows 
good neurotropism. One advantage of the AAV-2 virus is its lack of toxicity for in 
vivo expression studies because it does not generate an immune response nor 
inflammation at the site of injection.  Its main limitation is that packaging capacity is 
limited to transgenic inserts less than 5 Kb. Expression of the transgene takes several 
days to be detected in vivo but, due to the lack of toxicity, this virus is highly suitable 
for in vivo long-term expression and it is one of the vectors of choice for human gene 
therapy. More information on this viral system can be found in [73,74]. 
 Mouravlev and colleagues engineered a rAAV-2 expressing wild-type HA-
tagged CREB to study the relationship of CREB and memory impairment during 
aging in rats (Table 2) [75]. 
 
4.5 Moloney murine leukaemia retrovirus  
This retroviral vector is derived from the Moloney murine leukaemia oncoretrovirus 
(MLV).  MLVs are lipid-enveloped viruses containing two identical copies of a linear 
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single-stranded RNA genome.  These retroviruses have a relatively simple genome 
(around 10 kb) and structure and they integrate into the genome, permitting long-term 
transgene expression.   They have been used for several decades for stable transfer 
into mammalian cells and for gene therapy.  More information on this type of virus 
can be found in [76].  These viruses have not been exploited much for in vivo 
expression of transgenes in the brain. Indeed, their main limitation is that they can 
only infect dividing cells, and thus are not good for transduction of neurons.  Once 
inside a cell, they retro-transcribe their genome into DNA, which is then used to make 
more viral RNA and new viruses.  However, during this process, the DNA has to be 
moved to the nucleus and this can be achieved only when cells undergo a mitotic 
cycle. This feature has been successfully exploited to specifically transduce 
neuroprogenitor cells in the adult brain, what makes this type of viral vector a 
powerful research tool to investigate neurogenesis and neuronal lineage [77].  Thus, a 
recent study described the use of MLV-derived retroviruses expressing either ACREB 
or CREB
Y134F
 together with IRES-GFP or IRES-DsRed, to study the role of CREB in 
the maturation of adult newborn neurons of the dentate gyrus [78]. 
 
4.6 Lentivirus  
Lentiviruses (Lv) belong to a different subclass of retrovirus than the MLV. The early 
Lv vectors were based largely on the human immunodeficiency virus-1 (HIV-1).  This 
type of retrovirus has the major advantage that it can infect both growth-arrested and 
dividing cells, including neurons and glia. Lv vectors have been extensively 
developed over the last decades for efficient and safe research tools. The newest 
generations contain only few sequences of the HIV-1 genome and provide a transgene 
capacity of about 10kb. The viral particles are generated from three separate plasmids 
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to ensure that only replication-defective viruses are produced. They generally 
integrate into the host genome, making them suitable for long-term expression 
studies, but some types of vectors lack the integrase, which prevent genomic 
integration if desired.  More information on this type of viral vectors can be found in 
[79]. Lentiviruses have been used extensively in the last decade for neuroscience 
applications.  We are, however, not aware of its use yet for expression of CREB or 
CREB mutants.  Investigators have engineered lentiviruses to modulate the function 
of the CREB pathway by down-regulating TORCs or over-expressing CBP [80,81].  
 
5. CREB functions in the nervous system 
CREB participates in the regulation of neuronal responses to a variety of stimuli. For 
example, numerous neurotrophins and cytokines activate CREB, as do a host of other 
cellular perturbations that ultimately increase levels of cAMP or calcium. A large 
body of work establishes CREB as a critical component of the molecular switch that 
controls different forms of neuronal plasticity by regulating the expression of genes 
necessary to strengthen existing synaptic connections, to promote the formation of 
new ones and to modulate the intrinsic properties of the neurons. All these 
phenomena are thought to underlie learning and memory processes in the brain [11]. 
Below, we will focus on these functions and discuss the role of CREB in different 
forms of neuronal plasticity and memory that emerged from studies in which the 
activity of CREB have been genetically modified by transgenesis, gene targeting or 
virus transduction techniques. 
 
5.1 CREB and synaptic plasticity  
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Studies in the sea snail Aplysia, three decades ago, first established the critical role of 
the cAMP signaling pathway and CREB in long-term facilitation (LTF), the long-
term strengthening of synaptic connections that takes place during simple forms of 
learning and memory in this animal [82]. Most of the upstream signaling cascade 
leading to CREB activation appears to be conserved through evolution, and many 
aspects of the role of CREB in synaptic plasticity described in invertebrates have been 
also observed in long-term potentiation (LTP), which is the mammalian equivalent to 
LTF [83]. Pharmacological experiments distinguish two distinct phases of LTP, an 
early phase (E-LTP) that is resistant to inhibitors of transcription and translation, and 
a late phase (L-LTP) that is blocked by such compounds. It is though that E-LTP and 
L-LTP are the cellular correlates of short-term and long-term memory, respectively 
[84]. In hippocampal neurons, both CREB phosphorylation and the induction of a 
CRE-driven lacZ reporter construct are triggered in CA1 pyramidal neurons by 
electrical stimuli that induce L-LTP [85,86,87,88]. Although seminal studies in 
CREB mice revealed severe L-LTP impairments [25], this deficit appeared to be 
sensitive to different factors, such as gene dosage and genetic background. A 
comprehensive study using four different strains of CREB-deficient mice, including 
CREB hypomorphic mutants and neuron-restricted knockouts, failed to 
demonstrate any deficit in both LTP and long-term depression (LTD) in the Schaffer 
collateral pathway when robust induction protocols were used [89]. Other studies in 
CREB knockouts and transgenics have also failed to demonstrate deficits in LTP 
experiments in the hippocampus [90] and the amygdala [38], respectively. As 
discussed above, knocking out CREB/ isoforms causes the over-expression of 
other CRE-binding proteins, such as CREM and the CREB  isoform [24,26] that 
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may compensate for the deficiency in CRE-dependent activity and lead to an impaired 
LTP phenotype.  
 The use of transgenic strategies that cause a broader inhibition of CRE-driven 
gene expression has allowed studies of the role of the CREB pathway in synaptic 
plasticity without the associated problems of compensation by other CRE-binding 
proteins. For example, transgenic mice expressing KCREB, a dominant negative form 
of CREB that prevents its binding to DNA and that can also quench other factors 
capable of associating with CREB, showed clear deficits in different forms of L-LTP 
[47,91]. Similarly, transgenic mice expressing the strong dominant inhibitor ACREB 
also impaired L-LTP, but spared E-LTP [48] (Figure 2).  
Gain-of-function studies have consistently demonstrated that CREB activity 
(or more precisely, CRE-binding activity) is sufficient to enhance LTP. Transgenic 
mice [39,44,92] and sindbis virus-transduced rats [63] that express dominant active 
CREB variants show enhanced CRE-driven expression in CA1 pyramidal neurons 
and stronger LTP (e.g. Figure 2 and Figure 3b). Interestingly, Marie and colleagues 
found that the expression of CREB
Y134F
 also enhanced synaptic transmission of 
NMDA receptors, but not of AMPA receptors (Figure 3c) by increasing the number 
of silent synapses in CA1 pyramidal neurons [63], a change that can explain the 
facilitation of LTP observed in those animals. The over-expression of effector 
molecules downstream of CREB, such as the neurotrophin BDNF that promotes 
synaptic growth, can also contribute to the enhancement of LTP [93]. More recently, 
Marie and colleagues demonstrated that increasing CREB activity in granule cells of 
the dentate gyrus by viral in vivo expression of CREB
Y134F
, is also sufficient to 
enhance LTP in this structure [68]. Consistent with what has been described for LTF 
in Aplysia neurons [94], these studies suggest that the products generated after 
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activation of the CREB pathway provide the required support for synaptic 
strengthening. 
Overall, these data provide strong evidence supporting a key role for CREB 
and CRE-driven transcription in synaptic plasticity in rodents. However, some 
discrepancies between the results of groups using loss-of-function approaches may 
need additional clarification. The weak LTP phenotype observed in the forebrain- 
restricted knockout mice is particularly surprising [89]. This, together with the modest 
transcriptional alterations observed in different loss-of-function studies, suggest that 
other transcription factors may compensate for the lack of CREB [48,95,96]. 
Although CREB may be sufficient to trigger a transcriptional program able to sustain 
L-LTP [93], it is not always necessary.  
 
5.2 CREB and structural plasticity 
The concept of structural plasticity in memory storage was first described by Ramon y 
Cajal in the 1890‟s, when he suggested that a memory is stored in the growth of new 
synaptic connections. In agreement with this hypothesis, long-term facilitation (LTF) 
in Aplysia, which is though to be a cellular correlate of long-term memory formation, 
is accompanied by growth of new synaptic contacts [97]. Notably, this form of 
plasticity involves PKA-dependent CREB phosphorylation. Studies in mammals have 
also shown that spines are highly dynamic structures during memory formation and 
the cellular processes of LTP and LTD [98]. The definition of the exact role of CREB 
in this context is however still under investigation.  Evidence supports the notion that, 
like in invertebrates, CREB activation is intimately linked to spine formation in 
mammals. Work on cultured neurons have demonstrated that phosphorylation of 
CREB is necessary for estradiol-evoked spine formation [99]. Marie and colleagues 
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demonstrated that in vivo viral-mediated expression of CREB
Y134F
 is sufficient to lead 
to an increase in spine density in CA1 pyramidal neurons of young adult rats (Figure 
3d; [63]). The importance of CREB in homeostatic spine plasticity was also shown in 
a recent study on pyramidal neurons of the visual cortex of adult rats infected with an 
HSV vector expressing ACREB [56]. Suzuki and colleagues observed that CREB 
inhibition reduced spine head volume, but did not affect spine length or density. They 
also demonstrated that CREB plays an active role in homeostatic responses to activity 
suppression (by application of TTX) by controlling enlargement of spines heads and 
shortening of spine length. These observations suggest that CREB is a positive 
regulator of spine number and size.  
CREB is also involved in another form of structural plasticity in the mature 
brain: adult neurogenesis. CREB seems to regulate different phenomena during 
neurogenesis, both during development and in the adult. To date, CREB has been 
implicated in newborn neuron survival, maturation, and circuit integration [62,100]. 
Recent experiments with MLV vectors have demonstrated that loss of CREB in a cell-
autonomous manner decreases expression of the critical neurogenic factors (NeuroD 
and doublecortin) and compromises the survival of newborn neurons. These effects 
demonstrate that CREB signaling is a central component of adult hippocampal 
neurogenesis [78]. Similar experiments in the subventricular zone (SVZ) indicate that 
CREB signaling also plays an essential role in early stages of SVZ neurogenesis and 
the maturation of newborn neurons in the olfactory bulb [101]. 
 
5.3 CREB and intrinsic plasticity 
A number of recent studies have revealed a novel role for CREB and downstream 
gene expression in neural plasticity: the control of intrinsic excitability (i.e.  the 
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propensity of the neuron to fire action potentials in response to input signals) (see [11] 
for a recent and detailed review). CREB was first found to regulate neuronal firing in 
medium spiny neurons (MSNs) infected with recombinant sindbis viruses [64]. The 
expression of the constitutively active CREB
Y134F
 variant enhanced intrinsic 
excitability, whereas the expression of the dominant negative CREB
S133A
 mutant 
reduced it (Figure 3e). Similar results were observed in noradrenergic neurons of the 
locus coeruleus (LC) infected with recombinant HSV expressing either the 
constitutively active VP16-CREB variant, which increased intrinsic excitability, or 
the dominant negative CREB
S133A
 mutant that caused the opposite effect [55]. Studies 
in the hippocampus of bitransgenic mice expressing either VP16-CREB [45] or the 
dominant negative ACREB mutant [48] demonstrated that the excitability of CA1 
pyramidal neurons, in particular their post-burst after-hyperpolarization (AHP), was 
also severely affected by the genetic manipulation of CREB function (Figure 2). 
Recent studies in VP16-CREB bitransgenic mice or virus-transduced animals showed 
that the enhancement of CREB activity also produced a reduction of AHP in 
pyramidal neurons of the amygdala [58,102]. Overall, these results suggest that the 
modulation of intrinsic neuronal properties is a well-conserved CREB function.  
 
5.4 CREB and memory 
Substantial evidence in experimental systems ranging from mollusks to humans 
indicates that the CREB pathway is a core component of the molecular switch that 
converts short- to long-term memory. Studies in the sea snail Aplysia [82,103] and in 
the Drosophila fly [104,105,106] first established decades ago the importance of the 
cAMP and CREB signaling pathway in simple forms of learning and memory. In the 
mammalian brain, CREB is phosphorylated and CREB-dependent transcription is 
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induced in glutamatergic neurons after training in hippocampus-dependent and 
amygdala-dependent memory tasks [107,108,109].  
 This correlative evidence is complemented by genetic and pharmacological 
studies demonstrating that activation of the CREB pathway is not just a consequence 
of training, but plays an active role in learning and memory. A large number of 
behavioral studies have explored the learning and memory phenotype of CREB 
mutant strains and CREB virally transduced animals. CREB mice have a specific 
deficit in long-term memory revealed in several memory tasks [25]. This seminal 
study was soon replicated in rats, in which the intra-hippocampal infusion of CREB 
antisense oligos caused deficits in spatial learning [110]. However, other studies in 
CREB hypomorphic mutants indicated that the memory defect was sensitive to gene 
dosage and genetic background [90,111]. Moreover, as described before for LTP, the 
parallel behavioral analysis of four different strains of CREB-deficient mice by 
Balschun and colleagues failed to demonstrate any specific deficit in classical 
hippocampus-dependent tasks, including contextual fear conditioning and spatial 
learning in the water maze [89]. The apparent deficits in the Morris water maze found 
in some CREB mutants were better explained by an increase in thigmotaxis behavior 
rather than impaired spatial learning. A controversy regarding the role of CREB in 
memory is also seen in other behavioral tasks. For example, some fear conditioning 
studies have shown that CREB deficient mutants exhibited impaired fear conditioning 
[25,90,111], whereas others failed to reveal significant deficiencies [38,89]. These 
discrepancies suggest that, like for L-LTP, the loss of CREB may be compensated by 
the action of other CRE-binding transcription factors. As a consequence, the genetic 
approaches designed to overcome the obscuring effects of compensation have been 
more successful in revealing a role for CREB in learning and memory. Thus, 
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transgenic mice expressing the broad dominant negative mutant KCREB in the dorsal 
hippocampus showed spatial memory deficits that were reversed after turning off the 
transgene [47]. Similarly, transgenics expressing another broad dominant negative 
mutant ACREB also presented severe learning and memory deficits, although in this 
case the observation of concomitant hippocampal neurodegeneration prevented 
reliable conclusions concerning a specific role of CREB in memory [48]. Both 
compensatory and pleiotropic effects were successfully addressed by Kida and 
colleagues using the tamoxifen-regulated CREB variant described in section 3.5. 
Inducible and transient repression of CREB function specifically blocked the 
consolidation [50] and reconsolidation [51] of long-term fear memory and spatial 
memory in the watermaze [112]. Behavioral studies on mutant mice have also shown 
that inhibition of CREB leads to deficits in object recognition [47], socially 
transmitted food preferences [113], social memory [114], and conditional taste 
aversion [89]. 
 Gain-of-function transgenic approaches have been also successful for 
demonstrating a role for CREB in memory. Work by Viosca and colleagues in VP16-
CREB transgenic mice demonstrated that constitutive CREB activity in fear memory 
circuits can bypass the requirement for de novo gene expression associated with long-
term fear memory formation [102]. However, their experiments have also shown that 
the chronic and strong increase of CREB activity can have detrimental effects in 
memory performance since it interfered with the retrieval of spatial information in the 
watermaze [115]. More recently, the analysis of several transgenic lines exhibiting 
more moderate upregulation of CREB activity in the forebrain, CaMKII-CREB
Y134F
 
and CaMKII-CREB
DIEDML
 mice (two lines per strain), demonstrated that enhanced 
CREB improved long term memory in different tasks, including social recognition 
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memory, passive avoidance, contextual fear conditioning and spatial navigation [39]. 
Interestingly, some of these lines also exhibited enhanced short-term memory in 
contextual fear conditioning and social recognition tasks [39].  
 Studies using recombinant viruses also allow for acute genetic manipulation of 
CREB activity and have clearly supported a role for CREB in memory formation. 
Using recombinant HSVs, Josselyn and colleagues first demonstrated that the acute 
over-expression of CREB in amygdala facilitated the formation of long term memory 
[116], whereas the expression of a dominant negative CREB mutant inhibited it [117]. 
Later, the inhibition of CREB through the expression of dominant negative variants 
led to deficits in social transmission of food preferences [118] and striatal-dependent 
procedural learning [119], whereas gain-of-function approaches targeted to the 
hippocampus have successfully confirmed the enhancement of fear conditioning 
memory (Figure 3f; [66]) and supported a role for CREB in spatial memory 
[120,121]. Furthermore, Vetere et al. most recently demonstrated that increasing 
contextual fear memory by increasing CREB activity in the dentate gyrus does not 
prevent normal extinction of this memory [67]. Somatic gene transfer of CREB has 
been also shown to attenuate memory impairment in aging rats [75].  
 As in the case of transgenic studies, experiments with viral vectors have also 
raised some concern regarding the timing, location and duration of CREB 
manipulation. Increasing CREB in the auditory thalamus enhanced formation of an 
auditory conditioned fear memory, but caused broader auditory fear generalization 
[122]. Also, the over-expression of CREB in the basolateral amygdala decreased the 
number of escape failures in the learned helplessness model of depression when the 
virus was injected after training, but increased escape failures and other depressive 
effects when injected before training [123]. Expression of CREB in the basolateral 
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amygdala also increased diverse behavioral measures of anxiety [123]. This variety of 
effects can be explained considering the duration and strength of the perturbation of 
CREB pathway achieved in each of these studies. 
 Josselyn and colleagues elegantly demonstrated that the neurons over-
expressing CREB, via HSV viral vectors, were preferentially recruited to form a new 
fear memory [124], suggesting the existence of a competitive model underlying 
memory formation, in which eligible neurons are selected to participate in a memory 
trace as a function of their relative CREB activity at the time of learning (see the 
recent reviews on this topic by [125,126]). As a continuation of these experiments, 
Josselyn‟s group showed that the ablation of CREB-overexpressing neurons led to 
complete loss of the memory allocated in the infected neurons [57]. To achieve this, 
they engineered an HSV vector that expresses both GFP-CREB and cre recombinase 
(GFP-CREB-cre). They injected this virus into transgenic mice expressing simian 
diphtheria toxin receptor (DTR) in a cre recombinase-inducible manner. Upon 
infection of neurons with GFP-CREB-cre, these neurons expressed CREB, but also 
cre recombinase, which excised the loxP-flanked STOP cassette that silenced DTR 
expression, thereby allowing DTR expression. Injection of diphtheria toxin any time 
thereafter induced apoptosis only in virus-expressing cells. This innovative approach 
demonstrates how coupling the use of viruses with that of transgenic mice can provide 
unique and powerful strategies to selectively target and modify neurons in vivo and 
demonstrated a causal link between a molecularly defined neuronal population in the 
mammalian brain and the expression of a specific memory. 
 In agreement with this view, Zhou and colleagues have demonstrated that 
temporarily silencing CREB-transduced amygdala neurons during tone conditioning 
prevented memory formation [58]. To achieve this, they co-expressed CREB and the 
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Drosophila allatostatin receptor (AlstR) using an HSV vector, which turns on 
endogenous mammalian G protein-coupled inwardly rectifying potassium (GIRK) 
channels. Upon binding of allatostatin, the AlstR/GIRK complexes cause membrane 
hyper-polarization and, consequently, a decrease in neuronal excitability. They co-
expressed AlstR with GFP-CREB in the same HSV but driven by two independent 
promoters.  By in vivo infection of this virus in the amygdala, they could evaluate the 
effects of increased CREB-dependent transcription, but also how inactivation of these 
same neurons (by stereotaxic in vivo infusion of allatostatin at the site of viral 
infection) could perturb memory processes. Again these data demonstrate that CREB 
drives the allocation of fear memory to specific cells.  
 The impairments observed in most loss-of-function studies and the various 
effects of overactivation of the CREB pathway, from detrimental to beneficial, 
highlight the importance of proper and timely activation of the CREB pathway in 
learning and memory processes. 
 
5.5 Other aspects of CREB function in the nervous system 
When interpreting the behavioral and plasticity phenotype of mice with genetically 
altered levels of CREB activity, we should not forget that CREB plays important roles 
in neuronal physiology that may not be directly related with its function in plasticity. 
Particularly relevant is the strong evidence supporting a critical role for the CREB 
pathway in the development of the nervous system and neuronal survival. 
Diverse developmental processes in the nervous system have been associated 
with CREB function. CREB plays an important role in controlling proliferation, 
differentiation, and survival of newborn neurons [127,128,129]. CREB activity 
promotes the formation of dendrites and growth cones in cultures of embryonic 
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neurons or neuroblastoma cells [72,130], and probably also during development of the 
nervous system [129,131]. CREB also participates in different aspects of 
developmental plasticity, such as ocular dominance in the visual cortex or the 
formation of anatomical maps in the barrel cortex [132,133,134,135]. 
Regarding neuronal survival, experiments in neuronal cultures and CREB 
mutant mice indicate that some neuronal types have a complete requirement for 
CREB for survival, whereas others, particularly in the central nervous system, are less 
compromised after the elimination of CREB [19,28,29,30,31,48,129,136,137]. CREB 
is not only required for neuronal survival, but may also participate in the defensive 
response to injury [28,138]. A variety of studies have demonstrated that over-
expression of CREB or transient expression of a constitutively active CREB variant 
protected different types of neurons from apoptotic death, whereas dominant negative 
CREB mutants have the opposite effect [70,130,139]. Several studies indicate that 
CREB may also play a role in axonal repair [140,141,142]. However, the strong 
chronic activation of CREB in transgenic mice caused sporadic epileptic seizures and 
loss of hippocampal neurons, indicating that a fine-tuned regulation of CREB‟s 
function is required for neuronal survival and function [143]. 
Given the involvement of CREB in diverse critical aspects of neuronal 
function, it is not surprising that the consequences of malfunction in its pathway are 
severe. Thus, great effort has been put to understand the role of CREB in drug 
addiction [144,145], mental retardation syndromes caused by mutations of genes in 
the CREB signaling pathway [146,147], and neurodegenerative diseases in which the 
CREB pathway appears affected [12,148]. The genetic manipulation approaches 
described above should be, therefore, also very useful to explore the role of CREB in 
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these pathological conditions, as demonstrated, for example, by the investigation of 
the role of CREB in cocaine addiction [64,65,149]. 
 
6. Concluding remarks 
Technical advances in mouse genetics and viral expression systems have allowed the 
generation of new tools to alter CREB function in vivo. The anatomical and temporal 
restriction of the genetic manipulations combined with multidisciplinary approaches 
have allowed addressing fundamental biological questions related to CREB function 
unapproachable by previous efforts, such as its role in memory allocation and 
consolidation. Some significant discrepancies between studies still need to be clarified 
and recent findings have opened numerous novel questions concerning the role of 
CREB in the regulation of neuronal excitability and the allocation of new memories. 
Another important area for future research is to identify the particular gene programs 
that CREB activates in distinct neuronal contexts. Such studies will likely require use 
of emerging techniques for genome-wide analysis of gene expression and genome 
occupancy. With the challenges ahead in mind, the effort of several dozens research 
groups during the last fifteen years has greatly strengthened and refined our 
understanding of the role of the CREB-dependent transcription in learning and 
memory and have consolidated the position of the CREB pathway as one of the most 
attractive target for drugs aimed at restoring or protecting memory abilities under 
pathological situations, and also possibly to improve memory in the normal brain 
[150,151]. 
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Legends:  
Table 1:  CREB mutant strains 
Different mouse strains generated to manipulate CREB levels or activity in vivo.  The 
phenotypes observed and the publications related to each strain are indicated. 
 
Table 2: CREB recombinant viruses 
The viruses engineered to modify CREB function are described in this table together 
with the publications that used them in vivo.  Details of the virus backbone and the 
helper DNA used for viral production are reported in the „virus type‟ column, 
whenever this information was available in the publications.  
 
Figure 1. CREB structure and relevant residues.  
Left: CREB structure. CREB has a highly conserved leucine zipper and adjacent basic 
region responsible for DNA-binding, a regulatory kinase inducible domain (KID), and 
two glutamine-rich regions (Q1 and Q2). CREB is substrate of various 
posttranslational modifications that affect its activity, the position of residues 
potentially affected is indicated. The loss- and gain-of-function point mutations 
described in the text are also shown (adapted from [9]). Right: schematic 
representation of the constitutively active CREB variants ACREB (up) and VP16-
CREB (down). In the case of VP16-CREB, different groups have produced different 
versions of the chimeric protein with the VP16 domain located either in position N or 
C-terminal. In the protein presented here the VP16 domain replaces the Q1 domain 
[44].  
 
  45  
Figure 2: Evaluation of CREB function in synaptic plasticity and neuronal 
excitability using CREB transgenics. 
Schematic representation of CRE-driven gene expression in wild type mice (upon 
phosphorylation and recruitment of CBP, upper scheme), and in transgenic mice 
expressing a constitutively active CREB variant (VP16-CREB mice, left scheme) or a 
dominant negative inhibitor (ACREB mice, right scheme). Under the corresponding 
schemes we also present the results of the analyses of E-LTP and L-LTP in the 
Schaffer collateral pathway (data from [44] and [48], respectively) and excitability of 
CA1 pyramidal neurons (data from [45] and [48], respectively).  
 
Figure 3: Evaluation of CREB function in neuronal plasticity and hippocampal 
memory formation using sindbis-virus mediated in vivo expression of CREB 
mutants. 
a. Recombinant sindbis viruses expressing mutants of CREB and GFP were injected 
in vivo in the hippocampus (a-d, f) or nucleus accumbens (e).  Photos show strong 
GFP expression detected in slices from an infected young adult rat 24 hours after in 
vivo injection with a GFP-expressing sindbis virus: low resolution (4X; top panels) 
and high resolution (40X; bottom panels) images of hippocampal slices (left panels 
show DIC images; right panels show GFP fluorescence)  
b. In vivo expression of CREB
Y134F
 enhances LTP in CA1 pyramidal neurons. CA1 
neurons of young adult rats were infected with either GFP or CREB
Y134F
-IRES-GFP 
and LTP (induced at time 0 by 100Hz/1s protocol) whole-cell experiments were 
performed on acute slices from these infected rats 24 hours after infection. Uninf: 
uninfected control neurons in infected slices. 
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c. In vivo expression of CREB
Y134F
 enhances NMDAR-mediated but not AMPAR-
mediated synaptic transmission in CA1 pyramidal neurons. Average percent change 
of AMPA receptor (left) and NMDA receptor (right) currents of CREB
Y134F
-
expressing neurons of in vivo infected young adult rats relative to neighboring 
uninfected control neurons (sequential paired whole-cell recordings). Overlay of 
sample currents of pairs are shown above bar graphs (Scale bars: 20 msec/20 pA).  
d. In vivo expression of CREB
Y134F
 enhances spine density in CA1 pyramidal 
neurons.  Confocal micrograph of Alexa 568-filled secondary dendrite from a GFP-
expressing neuron after in vivo infection. Spine density was estimated in GFP and 
CREB
Y134F
-IRES-GFP infected neurons using confocal microscopy and 3D 
reconstruction of dendritic segments. 
e. In vivo CREB
Y134F
 and CREB
S133A
 expression increases and lowers, respectively, 
the intrinsic excitability of nucleus accumbens medium spiny neurons, as measured 
by the number of spikes elicited by a given injected current.  
f. In vivo expression of CREB
Y134F
 in CA1 pyramidal neurons or dentate gyrus (DG) 
granule cells enhances memory formation in the contextual fear conditioning (CFC) 
task.  Mice were injected with either GFP or CREB
Y134F
-IRES-GFP viruses bilaterally 
in the CA1 or in the DG and submitted to CFC training and testing (24 hours and 48 
hours after infection, respectively).  Freezing behavior was monitored during the 
training and test sessions and is reported in these graphs.  Enhanced freezing during 
the test session, reflecting better conditioning, was evident in both CA1- and DG- 
CREB
Y134F
-IRES-GFP infected mice compared to GFP-infected mice. Graphs and 
pictures adapted from [63,64,66]. 
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Table 1: CREB mutant strains 
 
Mouse strain Phenotype References 
CREB-/- 
(null mutation) 
http://www.informatics.jax.org/searches/allele.cgi?7148 
Perinatal death 
Axonal growth defects and degeneration of peripheral 
neurons 
[27,129] 
CREB = CREB-/- 
(hypomorphic mutation) 
http://www.informatics.jax.org/searches/allele.cgi?3853 
Up-regulation of CREB and CREM 
Non clear effects in CRE-driven gene expression 
Controversial LTP and memory phenotypes 
Complex addiction phenotype 
[24,25,26,89,90,95,111,113,1
34,152,153,154,155,156] 
CREBcomp = CREB-/- 
(hypomorphic/null mutation) 
Normal hippocampal LTP 
More severe behavioral defects than CREB 
[89,90] 
CREBf/f  (Schültz lab) 
(floxed CREB) 
http://www.informatics.jax.org/searches/allele.cgi?7157 
Neurodegeneration (CREM-/- double mutants) 
[28] 
CREBCaMKCre7 
(postnatal forebrain restricted knockout) 
Up-regulation of CREM  
Normal hippocampal LTP and LTD 
No effect in some hippocampus-dependent tasks  
[89] 
CREBNesCre 
(CNS restricted knockout) 
Dwarf phenotype 
Up-regulation of CREM  
Normal hippocampal LTP and LTD 
No effect in some hippocampus-dependent tasks, enhanced 
thigmotaxis, impaired CTA 
[89] 
CREBf/f (Nestler lab) 
(floxed CREB) 
http://www.informatics.jax.org/searches/allele.cgi?617152 
Altered opiate addiction 
[33] 
CREB(S142A) 
(knock-in point mutation) 
http://www.informatics.jax.org/searches/allele.cgi?7824 
Altered circadian rhythms and inflammatory nociception 
[34,36] 
CREB(S133A) 
(knock-in point mutation) 
http://www.informatics.jax.org/searches/allele.cgi?63712 
No neural phenotype has been investigated 
[35] 
PcP2-CREB 
(overexpression of wt protein) 
Unaltered LTP 
Impaired habituation to Rotarod 
[37] 
CaMKII-CREBA133 
(dominant negative transgene) 
Normal LTP in amygdala and hippocampus 
Mild fear conditioning impairment in one out of three lines 
[38] 
CaMKII-CREBY134F 
(dominant active transgene) 
Enhanced LTP in hippocampus 
Enhanced social recognition, contextual fear and passive 
avoidance memory 
[39] 
CaMKII-CREBDIEDML 
(dominant active transgene) 
Enhanced social recognition and contextual fear memory [39] 
NSE-tTA/tetO-CREB 
(inducible overexpression of wt protein) 
Depressant like effect 
 
[157,158,159] 
CaMKII-tTA/tetO-CREB 
(inducible overexpression of wt protein) 
Altered response to cocaine administration [43] 
NSE-tTA/tetO-CREB-M1 
(inducible dominant negative transgene) 
Anti-depressant like effect 
Inhibition of the differentiation and maturation of newborn 
neurons 
[43,159,160] 
CaMKII-tTA/tetO-KCREB 
(inducible dominant negative transgene) 
Impaired spatial learning and memory 
Deficits in some, but not all, forms of LTP 
[47,91 ,161,162]  
CaMKII-tTA/tetO-ACREB 
(inducible dominant negative transgene) 
Neurodegeneration and impaired memory 
Deficits in some forms of LTP 
[46,48,49 ,163,164]  
CaMKII-tTA/tetO-VP16CREB 
(inducible constitutively active 
transgene) 
Lower threshold for L-LTP in hippocampus, 
Altered learning and memory 
Enhanced ocular dominance plasticity in visual cortex 
[44,46,92,93,102,115 ,135]  
CaMKII-CREBIR 
(tamoxifen inducible repressor 
transgene) 
http://www.informatics.jax.org/searches/allele.cgi?32759 
Impaired consolidation of fear memories 
[50,51,112,117] 
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Table 2: CREB recombinant viruses 
 
Virus name  Insert(s) Virus type References  
HSV-CREB Wild-type CREB Herpes simplex virus type 1 
(HSV-PrpUC/helper 5dl1.2) 
[116,119,120,123,165,166,167,168,169] 
HSV-mCREB mCREB (S133A) (dominant 
negative) 
Herpes simplex virus type 1 
(HSV-PrpUC/helper 5dl1.2) 
[116,119,120,123,165,166,167,168,169] 
HSV-GFP-CREB Wild-type CREB fused to GFP Herpes simplex virus type 1 
(HSV-PrpUC/helper 5dl1.2) 
[54,55,121,122,124,167] 
HSV-GFP-CREBS133A mCREB (S133A) fused to GFP 
(dominant negative) 
Herpes simplex virus type 1 
(HSV-PrpUC/helper 5dl1.2) 
[54,55,121,122,124,167] 
HSV-GFP-VP16-
CREB 
CREB (fused to VP16) fused to 
GFP (constitutively active) 
Herpes simplex virus type 1 
(HSV-PrpUC/helper 5dl1.2) 
[55] 
HSV-GFP-CREBY134F CREB (Y134F) fused to GFP 
(constitutively active) 
Herpes simplex virus type 1 
(HSV-PrpUC/helper 5dl1.2) 
[124] 
HSV-FLAG-ACREB-
GFP 
FLAG-tagged ACREB 
(dominant negative) and GFP 
(independent promoters) 
Herpes simplex virus type 1 
(HSV-PrpUC/helper 5dl1.2) 
[56] 
HSV-GFP-CREB-cre Wild-type CREB fused to GFP 
followed by IRES-cre 
recombinase 
Herpes simplex virus type 1 
(HSV-PrpUC/helper 5dl1.2) 
[57] 
HSV-CREB-AlstR Wild-type CREB fused to GFP 
and Allatostatin receptor 
(independent promoters) 
Herpes simplex virus type 1 
(HSV-PrpUC/helper 5dl1.2) 
[58] 
SFV-CREB-GFP  Wild-type CREB and GFP 
(independent promoters) 
Low-toxicity semiliki Forest virus 
(pSFVpd/pSFVhelper2) 
[62] 
SFV-CREBS133A-GFP  mCREB (S133A; dominant 
negative) and GFP 
(independent promoters) 
Low-toxicity semiliki Forest virus 
(pSFVpd/pSFVhelper2) 
[62] 
SFV-CREBR287L-GFP KCREB (R287L; dominant 
negative) and GFP 
(independent promoters) 
Low-toxicity semiliki Forest virus 
(pSFVpd/pSFVhelper2) 
[62] 
SFV-VP16-CREB-
GFP 
VP16-CREB fusion protein 
(constitutively active) and GFP 
(independent promoters) 
Low-toxicity semiliki Forest virus 
(pSFVpd/pSFVhelper2) 
[62] 
Sind-FLAG-
CREBY134F-IRES-GFP 
FLAG-tagged CREB (Y134F; 
constitutively active) followed 
by IRES-GFP  
Sindbis virus (pSINrep-5/helper 
DH(26S) 
[63,64,65] 
Sind-FLAG-
CREBS133A-IRES-GFP 
FLAG-tagged mCREB 
(S133A; dominant negative) 
followed by IRES-GFP 
Sindbis virus (pSINrep-5/helper 
DH(26S)) 
[64,65] 
Sind(nsp2s)- FLAG-
CREBY134F-IRES-GFP 
FLAG-tagged CREB (Y134F; 
constitutively active) followed 
by IRES-GFP 
Low toxicity Sindbis virus (pSINrep-
nsP2S726/helper  
DH/BB(tRNA/TE12)) 
[66,67,68] 
Ad5-CREB-IRES-GFP Wild-type CREB followed by 
IRES-GFP 
E1-deleted human adenovirus type 5 
(pXCXCMV) 
[70,71] 
Ad5-ACREB-IRES-
GFP 
ACREB (dominant negative) 
followed by IRES-GFP 
 
E1-deleted human adenovirus type 5 
(pXCXCMV) 
[70,71] 
Ad5-VP16-CREB-GFP 
(tTA/TetO) 
VP16-GFP (constitutively 
active) and GFP (independent 
promoters) 
E1/E3-deleted human adenovirus 
type 5 
 
[72] 
rAAV2-HA-CREB HA-tagged wild-type CREB Recombinant adeno-associated virus 
(rAAV-2 /helpers ACG2/pXX6) 
[75] 
CAG-CREBY134F-
IRES-DSRED 
CREB (Y134F; constitutively 
active) followed by IRES-GFP 
MoMLV-derived retrovirus (CAG 
vector/CMV-VsVg/CMV-gag/pol) 
[78]  
CAG-ACREB-IRES-
GFP 
ACREB (dominant negative) 
followed by IRES-DSRED 
MoMLV-derived retrovirus (CAG 
vector/CMV-VsVg/CMV-gag/pol) 
[78,101] 
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